Cargando…
Advances of Targeted Therapy in Treatment of Unresectable Metastatic Colorectal Cancer
Despite being one of the most frequently diagnosed cancers worldwide, prognosis of metastatic colorectal cancer (CRC) was poor. Development and introduction of biologic agents in treatment of patients with metastatic CRC have brought improved outcomes. Monoclonal antibodies directing epidermal growt...
Autores principales: | Lee, Suk-young, Oh, Sang Cheul |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4835624/ https://www.ncbi.nlm.nih.gov/pubmed/27127793 http://dx.doi.org/10.1155/2016/7590245 |
Ejemplares similares
-
Metastatic Colorectal Cancer. First Line Therapy for Unresectable Disease
por: Aparicio, Jorge, et al.
Publicado: (2020) -
The Inositide Signaling Pathway As a Target for Treating Gastric Cancer and Colorectal Cancer
por: Kim, Hong Jun, et al.
Publicado: (2016) -
Pembrolizumab for first-line treatment of advanced unresectable or metastatic esophageal or gastroesophageal junction cancer
por: Hirose, Toshiharu, et al.
Publicado: (2023) -
Novel Systemic Therapies for Advanced Gastric Cancer
por: Kim, Hong Jun, et al.
Publicado: (2018) -
Immunotherapies and Targeted Therapies in the Treatment of Metastatic Colorectal Cancer
por: Rawla, Prashanth, et al.
Publicado: (2019)